Bladder cancer - Clinical trials 

  • Clinical trials

Clinical trials for Bladder cancer

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Bladder cancer. For all clinical trials, go to clinical trials search

This list shows clinical trials for Bladder cancer

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Bladder cancer
Title Recruitment status Location
A Phase III randomised trial of PeriOperative chemotherapy versus sUrveillance in upper Tract urothelial cancer Recruiting United Kingdom
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor Recruiting United Kingdom
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer Recruiting United Kingdom
Lapatinib Ditosylate in Treating Patients With Stage IV Bladder Cancer Recruiting United Kingdom
HYMN: A trial comparing hyperthermia and mitomycin chemotherapy with a second BCG treatment, or other standard treatment, for bladder cancer that has come back Recruiting United Kingdom
Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer Recruiting United Kingdom
Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer Recruiting United Kingdom
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom Recruiting United Kingdom
Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium Recruiting United Kingdom
Phase I/II feasibility study of cetuximab with 5-fluorouracil (5FU) and mitomycin C or cisplatin with concurrent radiotherapy in muscle invasive bladder cancer Recruiting United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member